PHASE IIA TO EVALUATE LUNG BIOEFFICACY OF DMP777 IN ADULTS W/ Cystic Fibrosis
PHASE IIA TO EVALUATE LUNG BIOEFFICACY OF DMP777 IN ADULTS W/ Cystic Fibrosis
批准号:
6264332
负责人:
RICHARD Barry MOSS
金额:
$0.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cystic fibrosis, a common lethal genetic disorder, is characterized by a neutrophilic inflammatory exudate in the airways which causes bronchiectasis and eventual respiratory failure. Neutrophil elastase is believed to mediate many of the pathologic processes such as destruction of airway supporting tissue, mucus hypersecretion, opsonic deficiency, and cytokine secretion. DMP777 is a synthetic monobactam that penetrates the neutrophil to inhibit both intra- and extracellular elastase in a selective and essentially irreversible fashion. This study is a dose-escalating protocol to examine safety, pharmacokinetics, and pharmacodynamics of DMP777 in patients with CF by direct measurement of drug levels and elastase inhibition in bronchoalvolar fluids.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PHASE I/II, SINGLE-CENTER, BLINDED, RANDOMIZED, CONTROLLED STUDY OF XOLAIR
-
批准号:7605198
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2007
-
负责人:RICHARD Barry MOSS
-
依托单位:
CLINICAL TRIAL: VX-770 CFTR ACTIVITY IN CYSTIC FIBROSIS (CF) SUBJECTS WITH GENOT
-
批准号:7717937
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2007
-
负责人:RICHARD Barry MOSS
-
依托单位:
PTC124 AS AN ORAL TREATMENT FOR NONSENSE-MUTATION-MEDIATED CYSTIC FIBROSIS
-
批准号:7605255
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2007
-
负责人:RICHARD Barry MOSS
-
依托单位:
CLINICAL TRIAL: XOLAIR IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS WIT
-
批准号:7717865
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2007
-
负责人:RICHARD Barry MOSS
-
依托单位:
DIABETES THERAPY IN CF PATIENTS WITH ABNORMAL GLUCOSE TOLERANCE
-
批准号:7605163
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2007
-
负责人:RICHARD Barry MOSS
-
依托单位:
CLINICAL TRIAL: TETRASODIUM IN PATIENTS WITH MILD CYSTIC FIBROSIS LUNG DISEASE
-
批准号:7717914
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2007
-
负责人:RICHARD Barry MOSS
-
依托单位:
EVALUATE ANTI-INFLAMMATORY AGENTS IN PATIENTS WITH CYSTIC FIBROSIS
-
批准号:7605199
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2007
-
负责人:RICHARD Barry MOSS
-
依托单位:
DIABETES THERAPY IN CF PATIENTS WITH ABNORMAL GLUCOSE TOLERANCE
-
批准号:7375192
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2005
-
负责人:RICHARD Barry MOSS
-
依托单位:
HETEROGENEITY AMONG HUMAN CD4+ T-CELL CLONES
-
批准号:7375185
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2005
-
负责人:RICHARD Barry MOSS
-
依托单位:
TO EVALUATE ANTI-INFLAMMATORY AGENTS IN PATIENTS WITH CYSTIC FIBROSIS
-
批准号:7375258
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2005
-
负责人:RICHARD Barry MOSS
-
依托单位:
(INS37217) INHALATION SOLUTION IN PATIENTS WITH CYSTIC FIBROSIS LUNG DISEASE
-
批准号:7375301
-
项目类别:
-
资助金额:$0.89万
-
财政年份:2005
-
负责人:RICHARD Barry MOSS
-
依托单位:
XOLAIR IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS WITH FOOD ALLERGY
-
批准号:7375254
-
项目类别:
-
资助金额:$1.87万
-
财政年份:2005
-
负责人:RICHARD Barry MOSS
-
依托单位:
DIABETES THERAPY IN CYSTIC FIBROSIS PATIENTS WITH ABNORMAL GLUCOSE TOLERANCE
-
批准号:7202021
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2004
-
负责人:RICHARD Barry MOSS
-
依托单位:
TREATMENT WITH BIIL 284 BS IN ADULT AND PEDIATRIC CYSTIC FIBROSIS PATIENTS
-
批准号:7202079
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2004
-
负责人:RICHARD Barry MOSS
-
依托单位:
PHASE IIA TO EVALUATE LUNG BIOEFFICACY OF DMP777 IN ADULTS W/ Cystic Fibrosis
-
批准号:6486029
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:RICHARD Barry MOSS
-
依托单位:
ASCENDING INHALED DOSES OF IB 367 IN CYSTIC FIBROSIS
-
批准号:6486095
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:RICHARD Barry MOSS
-
依托单位:
AEROSOLIZED TGAAVCF FOR CYSTIC FIBROSIS THERAPY
-
批准号:6486077
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:RICHARD Barry MOSS
-
依托单位:
PHASE IIA TO EVALUATE LUNG BIOEFFICACY OF DMP777 IN ADULTS W/ Cystic Fibrosis
-
批准号:6305119
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1999
-
负责人:RICHARD Barry MOSS
-
依托单位:
PHASE II STUDY OF MULTIPLE DOSES OF DMP-777 IN ADULTS WITH CYSTIC FIBROSIS
-
批准号:6115073
-
项目类别:
-
资助金额:$4.03万
-
财政年份:1998
-
负责人:RICHARD Barry MOSS
-
依托单位:
PHASE II STUDY OF MULTIPLE DOSES OF DMP-777 IN ADULTS WITH CYSTIC FIBROSIS
-
批准号:6219382
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:RICHARD Barry MOSS
-
依托单位:
海外基金